Transenterix Inc (NYSEAMERICAN:TRXC) fell 5.5% during trading on Wednesday . The stock traded as low as $1.88 and last traded at $1.90. 3,438,579 shares changed hands during trading, an increase of 34% from the average session volume of 2,558,818 shares. The stock had previously closed at $2.01.
Several brokerages have recently commented on TRXC. Zacks Investment Research raised Transenterix from a “sell” rating to a “hold” rating in a research note on Tuesday, January 23rd. BTIG Research reissued a “hold” rating on shares of Transenterix in a research note on Monday, December 18th. Finally, Stifel Nicolaus boosted their price target on Transenterix from $3.75 to $4.00 and gave the stock a “buy” rating in a research note on Tuesday, October 31st. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $2.61.
The stock has a market cap of $392.51, a P/E ratio of -3.06 and a beta of 2.20.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3229044/transenterix-trxc-stock-price-down-5-5.html.
Transenterix Company Profile
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.